(Q34485493)

2 August 2017

1 reference

title

Prophylaxis and treatment of gastrointestinal complications following transplantation (English)

1 reference

2 August 2017

Helderman JH

1

1 reference

2 August 2017

1 January 2001

1 reference

2 August 2017

Clinical Transplantation

1 reference

2 August 2017

15 Suppl 4

1 reference

2 August 2017

29-35

1 reference

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Gastrointestinal complications after renal transplantation: predictive factors and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Prevention of duodenal ulcer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Management of severe pancreatitis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2001.00029.X

10.1111/J.1399-0012.2001.00029.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11778785